Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2009-11-10
pubmed:abstractText
Systemic gene delivery systems are needed for therapeutic application to organs that are inaccessible by percutaneous injection. Currently, the main objective is the development of a stable and non-toxic vector that can encapsulate and deliver foreign genetic material to target cells. To this end, DNA, complexed with cationic lipids i.e. DOTAP/DOPE, was encapsulated into lipid nanocapsules (LNCs) leading to the formation of stable nanocarriers (DNA LNCs) with a size inferior to 130 nm. Amphiphilic and flexible poly (ethylene glycol) (PEG) polymer coatings [PEG lipid derivative (DSPE-mPEG(2000)) or F108 poloxamer] at different concentrations were selected to make DNA LNCs stealthy. Some of these coated lipid nanocapsules were able to inhibit complement activation and were not phagocytized in vitro by macrophagic THP-1 cells whereas uncoated DNA LNCs accumulated in the vacuolar compartment of THP-1 cells. These results correlated with a significant increase of in vivo circulation time in mice especially for DSPE-mPEG(2000) 10 mm and an early half-life time (t(1/2) of distribution) 5-fold greater than for non-coated DNA LNCs (7.1 h vs 1.4 h). Finally, a tumor accumulation assessed by in vivo fluorescence imaging system was evidenced for these coated LNCs as a passive targeting without causing any hepatic damage.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1878-5905
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
321-9
pubmed:meshHeading
pubmed-meshheading:19800113-Animals, pubmed-meshheading:19800113-Cell Death, pubmed-meshheading:19800113-Cell Line, pubmed-meshheading:19800113-Complement System Proteins, pubmed-meshheading:19800113-DNA, pubmed-meshheading:19800113-Gene Transfer Techniques, pubmed-meshheading:19800113-Genetic Vectors, pubmed-meshheading:19800113-Humans, pubmed-meshheading:19800113-Injections, Intravenous, pubmed-meshheading:19800113-Kinetics, pubmed-meshheading:19800113-Lipids, pubmed-meshheading:19800113-Macrophages, pubmed-meshheading:19800113-Mice, pubmed-meshheading:19800113-Mice, Nude, pubmed-meshheading:19800113-Microscopy, Fluorescence, pubmed-meshheading:19800113-Nanocapsules, pubmed-meshheading:19800113-Neoplasms, pubmed-meshheading:19800113-Particle Size, pubmed-meshheading:19800113-Phosphatidylethanolamines, pubmed-meshheading:19800113-Surface Properties, pubmed-meshheading:19800113-Time Factors, pubmed-meshheading:19800113-Tissue Distribution
pubmed:year
2010
pubmed:articleTitle
Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting.
pubmed:affiliation
Inserm U646, Université d'Angers, 10 rue André Boquel, F-49100 Angers, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't